Comera Life Sciences Holdings Inc
OTC:CMRA
Income Statement
Earnings Waterfall
Comera Life Sciences Holdings Inc
Income Statement
Comera Life Sciences Holdings Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
+52%
|
1
+16%
|
1
+42%
|
1
-21%
|
1
+47%
|
1
+18%
|
1
-9%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
+40%
|
0
+35%
|
0
+58%
|
0
-11%
|
1
+53%
|
1
+26%
|
1
-10%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(6)
|
(10)
|
(12)
|
(15)
|
(12)
|
(19)
|
(10)
|
(10)
|
|
| Selling, General & Administrative |
(4)
|
(7)
|
(10)
|
(12)
|
(11)
|
(11)
|
(9)
|
(8)
|
|
| Research & Development |
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
|
| Operating Income |
(6)
N/A
|
(10)
-82%
|
(12)
-21%
|
(14)
-20%
|
(12)
+17%
|
(19)
-55%
|
(10)
+49%
|
(9)
+4%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
0
|
3
|
5
|
2
|
2
|
2
|
1
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
(6)
|
(6)
|
(7)
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
0
|
|
| Pre-Tax Income |
(5)
N/A
|
(7)
-30%
|
(14)
-100%
|
(20)
-44%
|
(18)
+12%
|
(18)
+2%
|
(10)
+44%
|
(9)
+9%
|
|
| Net Income | |||||||||
| Income from Continuing Operations |
(5)
|
(7)
|
(14)
|
(20)
|
(18)
|
(18)
|
(10)
|
(9)
|
|
| Net Income (Common) |
(5)
N/A
|
(7)
-30%
|
(14)
-103%
|
(21)
-44%
|
(18)
+12%
|
(18)
+2%
|
(10)
+43%
|
(9)
+9%
|
|
| EPS (Diluted) |
-0.29
N/A
|
-0.37
-28%
|
-0.75
-103%
|
-1.29
-72%
|
-1.76
-36%
|
-0.94
+47%
|
-0.53
+44%
|
-0.4
+25%
|
|